A History of Bone Marrow Transplantation

Immunology and Allergy Clinics of North America

Volumn 30, Issue 1, 2010, Pages 1-15

  de la Morena, M Teresa ^a   Gatti, Richard A ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Macdonald Research Laboratories ^*  (United States)

Author keywords

Bone marrow transplantation; History; Primary immunodeficiency diseases

Indexed keywords

AZATHIOPRINE; BCG VACCINE; BUSULFAN; CHLORAMPHENICOL; CYCLOPHOSPHAMIDE; HLA A ANTIGEN; HLA B ANTIGEN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 21 RECEPTOR; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 9 RECEPTOR; PLERIXAFOR; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RNA; THYMOCYTE ANTIBODY;

ANTIGEN RECOGNITION; APLASTIC ANEMIA; BONE MARROW TRANSPLANTATION; CLINICAL TRIAL; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HISTORY OF MEDICINE; HLA SYSTEM; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; LIFE EXPECTANCY; LUNG TUBERCULOSIS; MEDICAL EXPERT; NONHUMAN; ONCOLOGY; PEDIGREE ANALYSIS; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RNA INTERFERENCE; SEVERE COMBINED IMMUNODEFICIENCY; WISKOTT ALDRICH SYNDROME;

ALLERGY AND IMMUNOLOGY; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MEDICAL ONCOLOGY;

EID: 74749086546     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2009.11.005     Document Type: Review

References (104)

1. Bekkum D.W., and van de Vries M.J. Radiation chimaeras (1967), Logos Press, London p. 277
2. The Medical College of Wisconsin and The National Marrow Donor Program. Center for International Blood and Marrow Transplant Research (CIBMTR). Available at: (2008). http://www.cibmtr.org/ 2008. Accessed October 28, 2009
3. Good R.A., Kapoor N., and Reisner Y. Bone marrow transplantation-an expanding approach to treatment of many diseases. Cell Immunol 82 1 (1983) 36-54
4. Quine W.M.E. The remedial application of bone marrow. JAMA 26 (1896) 1012
5. Tiselius A., and Kabat E.A. An electrophoretic study of immune sera and purified antibody preparations. J Exp Med 69 (1939) 119-131
6. White T.F., and Dougherty A. Functional alterations in lymphoid tissue induced by adrenal cortical secretion. Am J Anat 77 (1945) 81-116
7. Medawar P.B. The experimental study of skin grafts. Br Med Bull 3 (1945) 79
8. Owen R. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 28 (1945) 400
9. Loeb L. Heredity and internal secretion in the spontaneous development of cancer in mice. Science 42 1095 (1915) 912-914
10. Gorer P.A. The detection of antigenic differences in mouse erythrocytes by employment of immune sera. Br J Exp Pathol 17 (1936) 21
11. Snell G.D., and Stevens L.C. Histocompatibility genes of mice. III. H-1 and H-4, two histocompatibility loci in the first linkage group. Immunology 4 (1961) 366-379
12. Snell G.D. Histocompatibility genes of the mouse. I. Demonstration of weak histocompatibility differences by immunization and controlled tumor dosage. J Natl Cancer Inst 20 4 (1958) 787-824
13. Snell G.D., and Jackson R.B. Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines. J Natl Cancer Inst 21 5 (1958) 843-877
14. Billingham R.E., Brent L., and Medawar P.B. Actively acquired tolerance of foreign cells. Nature 172 (1953) 603-606
15. Jacobson L.O., Simmons E.L., Marks E.K., et al. Recovery from radiation injury. Science 113 (1951) 510-511
16. Barnes D.W., Ford C.E., Ilbery P.L., et al. Tissue transplantation in the radiation chimera. J Cell Physiol Suppl 50 Suppl 1 (1957) 123-138
17. Main J.M., and Prehn R.T. Successful skin homografts after the administration of high dosage X radiation and homologous bone marrow. J Natl Cancer Inst 15 4 (1955) 1023-1029
18. Ford C.E., Hamerton J.L., Barnes D.W., et al. Cytological identification of radiation-chimaeras. Nature 177 4506 (1956) 452-454
19. Crouch B.G., and Overman R.R. Chemical protection against x-radiation death in primates: a preliminary report. Science 125 3257 (1957) 1092
20. Mathé G., Jammet H., Pendie N., et al. Transfusions et greffes de moelle osseuse homologue chez des humaine irradies a haute dose accidentellement. Nouvelle rev franc hematol 4 (1959) 226
21. Mathe G., Amiel J.L., Schwarzenberg L., et al. Adoptive immunotherapy of acute leukemia: experimental and clinical results. Cancer Res 25 9 (1965) 1525-1531
22. Thomas E.D., Lochte Jr. H.L., Lu W.C., et al. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257 11 (1957) 491-496
23. Bruton O.C. Agammaglobulinemia. Pediatrics 9 6 (1952) 722-728
24. Bruton O.C., Apt L., Gitlin D., et al. Absence of serum gamma globulins. AMA Am J Dis Child 84 5 (1952) 632-636
25. Medici M.A., Kagan R.M., Menkes J., et al. Chronic progressive panencephalitis in hypogammaglobulinemia: a literature review. In: JMR Foundation (Ed). Immunodeficiency. Its nature and etiological significance in human diseases (1978), University of Tokyo Press, Tokyo 149-160
26. Mannick J.A., Lochte Jr. H.L., Ashley C.A., et al. Autografts of bone marrow in dogs after lethal total-body radiation. Blood 15 (1960) 255-266
27. Miller M.E. Thymic dysplasia ("Swiss agammaglobulinemia"). I. Graft versus host reaction following bone-marrow transfusion. J Pediatr 70 5 (1967) 730-736
28. Bregsma D, Good RA, editors. Immunologic deficiency in man. Birth defects original articles series, vol. 4. White Plains (NY): The National Foundation-March of Dimes; 1968.
29. de Vries MJ, Dooren LJ, Cleton FJ. Graft versus host or autoimmune lesions in the Swiss type of agammaglobulinemia. In: Bergsma D, editor. Immunologic Deficiency in Man. Birth defects original articles series, vol. 4. White Plains (NY): National Foundation-March of Dimes; 1968. p.173.
30. Hong R., Cooper M.D., Allan M.J., et al. Immunological restitution in lymphopenic immunological deficiency syndrome. Lancet 1 7541 (1968) 503-506
31. Dausset J. [Presence of A & B antigens in leukocytes disclosed by agglutination tests]. C R Seances Soc Biol Fil 148 19-20 (1954) 1607-1608 [in French]
32. van Rood J.J., van Leeuwen A., and van Santen M.C. Anti HL-A2 inhibitor in normal human serum. Nature 226 5243 (1970) 366-367
33. Payne R., and Rolfs M.R. Fetomaternal leukocyte incompatibility. J Clin Invest 37 12 (1958) 1756-1763
34. Amos D.B. Genetic and antigenetic aspects of human histocompatibility systems. Adv Immunol 10 (1969) 251-297
35. Amos D.B., Seigler H.F., Southworth J.G., et al. Skin graft rejection between subjects genotyped for HL-A. Transplant Proc 1 1 (1969) 342-346
36. Ceppellini R., and van Rood J.J. The HL-A system. I. Genetics and molecular biology. Semin Hematol 11 3 (1974) 233-251
37. Terasaki P.I., and McClelland J.D. Microdroplet assay of human serum cytotoxins. Nature 204 (1964) 998-1000
38. Simonsen M. Graft versus host reactions. Their natural history, and applicability as tools of research. Prog Allergy 6 (1962) 349-467
39. Good R.A., Martinez C., and Gabrielsen A.E. Progress toward transplantation of tissues in man. Adv Pediatr 13 (1964) 93-127
40. Storb R., Epstein R.B., Bryant J., et al. Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6 4 (1968) 587-593
41. Thomas E.D., Epstein R.B., Eschbach Jr. J.W., et al. Treatment of leukemia by extracorporeal irradiation. N Engl J Med 273 (1965) 6-12
42. Good R.A., and Fisher D.W. In: Good R.A., and Fisher D.W. (Eds). Immunobiology: current knowledge of basic concepts in immunology and their clinical applications (1971), Sinauer Associates, Stamford (CT) 305
43. Good RA. Immunologic reconstitution: the achievement and it's meaning. In: Bergsma D, Good RA, editors. Birth defects original articles series, vol. 4. White Plains (NY): The National Foundation-March of Dimes; 1968.
44. Gatti R.A., Meuwissen H.J., Allen H.D., et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 2 7583 (1968) 1366-1369
45. Meuwissen H.J., Gatti R.A., Terasaki P.I., et al. Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatibility matching. N Engl J Med 281 13 (1969) 691-697
46. Gatti R.A., Meuwissen H.J., Terasaki P.I., et al. Recombination within the HL-A locus. Tissue Antigens 1 5 (1971) 239-241
47. Gatti R.A., and Good R.A. Follow-up of correction of severe dual system immunodeficiency with bone marrow transplantation. J Pediatr 79 3 (1971) 475-479
48. Bach F.H., Albertini R.J., Joo P., et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 2 7583 (1968) 1364-1366
49. Meuwissen H.J., Bortin M.M., Bach F.H., et al. Long-term survival after bone marrow transplantation: a 15-year follow-up report of a patient with Wiskott-Aldrich syndrome. J Pediatr 105 3 (1984) 365-369
50. Bortin M.M. A compendium of reported human bone marrow transplants. Transplantation 9 6 (1970) 571-587
51. Thomas E.D., Storb R., Clift R.A., et al. Bone-marrow transplantation (second of two parts). N Engl J Med 292 17 (1975) 895-902
52. Gatti R.A., Kemple K., Schwartzmann J., et al. HLA-D typing with lymphoblastoid cell lines. VI. Rationale and goals of data reduction. Tissue Antigens 14 3 (1979) 183-193
53. Gatti R.A., Kempner D.H., and Leibold W. The role of the MHC antigens in the mature and immature host. Pediatrics 64 5 Pt 2 Suppl (1979) 803-813
54. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for severe combined immunodeficiency with HLA-A, B, D, DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 61 2 (1983) 341-348
55. O'Reilly R.J., Keever C.A., Small T.N., et al. The use of HLA-non-identical T-cell-depleted marrow transplants for correction of severe combined immunodeficiency disease. Immunodefic Rev 1 4 (1989) 273-309
56. Buckley R.H., Schiff S.E., Sampson H.A., et al. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation. J Immunol 136 7 (1986) 2398-2407
57. Dror Y., Gallagher R., Wara D.W., et al. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 81 8 (1993) 2021-2030
58. Buckley R.H., Schiff S.E., Schiff R.I., et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340 7 (1999) 508-516
59. de Witte T., Hoogenhout J., de Pauw B., et al. Depletion of donor lymphocytes by counterflow centrifugation successfully prevents acute graft-versus-host disease in matched allogeneic marrow transplantation. Blood 67 5 (1986) 1302-1308
60. Lowenberg B., Wagemaker G., van Bekkum D.W., et al. Graft-versus-host disease following transplantation of 'one log' versus 'two log' T-lymphocyte-depleted bone marrow from HLA-identical donors. Bone Marrow Transplant 1 2 (1986) 133-140
61. Rodt H., Kolb H.J., Netzel B., et al. Effect of anti-T-cell globulin on GVHD in leukemic patients treated with BMT. Transplant Proc 13 1 Pt 1 (1981) 257-261
62. Filipovich A.H., McGlave P., Ramsay N.K., et al. Treatment of donor bone marrow with OKT3 (PAN-T monoclonal antibody) for prophylaxis of graft-vs.-host disease (GvHD) in histocompatible allogeneic bone marrow transplantation (BMT): a pilot study. J Clin Immunol 2 Suppl 3 (1982) 154S-157S
63. Filipovich A.H., McGlave P.B., Ramsay N.K., et al. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation. Lancet 1 8284 (1982) 1266-1269
64. Martin P.J., Hansen J.A., and Thomas E.D. Preincubation of donor bone marrow cells with a combination of murine monoclonal anti-T-cell antibodies without complement does not prevent graft-versus-host disease after allogeneic marrow transplantation. J Clin Immunol 4 1 (1984) 18-22
65. Umiel T., Daley J.F., Bhan A.K., et al. Acquisition of immune competence by a subset of human cortical thymocytes expressing mature T cell antigens. J Immunol 129 3 (1982) 1054-1060
66. Ho V.T., and Soiffer R.J. The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation. Blood 98 12 (2001) 3192-3204
67. Krause D.S., Fackler M.J., Civin C.I., et al. CD34: structure, biology, and clinical utility. Blood 87 1 (1996) 1-13
68. Cashen A.F. Plerixafor hydrochloride: a novel agent for the mobilization of peripheral blood stem cells. Drugs Today (Barc) 45 7 (2009) 497-505
69. Greinix H.T., and Worel N. New agents for mobilizing peripheral blood stem cells. Transfus Apher Sci 41 1 (2009) 67-71
70. Kessinger A., Armitage J.O., Smith D.M., et al. High-dose therapy and autologous peripheral blood stem cell transplantation for patients with lymphoma. Blood 74 4 (1989) 1260-1265
71. Pidala J., Anasetti C., Kharfan-Dabaja M.A., et al. Decision analysis of peripheral blood versus bone marrow hematopoietic stem cells for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 15 11 (2009) 1415-1421
72. Gallardo D., de la Camara R., Nieto J.B., et al. Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study. Haematologica 94 9 (2009) 1282-1288
73. Gorin N.C., Labopin M., Blaise D., et al. Higher incidence of relapse with peripheral blood rather than marrow as a source of stem cells in adults with acute myelocytic leukemia autografted during the first remission. J Clin Oncol 27 24 (2009) 3987-3993
74. Gluckman E., Broxmeyer H.A., Auerbach A.D., et al. Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321 17 (1989) 1174-1178
75. Gluckman E., Rocha V., Boyer-Chammard A., et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 337 6 (1997) 373-381
76. Gluckman E., and Rocha V. Cord blood transplantation: state of the art. Haematologica 94 4 (2009) 451-454
77. Knutsen A.P., and Wall D.A. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. J Clin Immunol 20 6 (2000) 466-476
78. Bhattacharya A., Slatter M.A., Chapman C.E., et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 36 4 (2005) 295-299
79. Hacke K., Falahati R., Flebbe-Rehwaldt L., et al. Suppression of HLA expression by lentivirus-mediated gene transfer of siRNA cassettes and in vivo chemoselection to enhance hematopoietic stem cell transplantation. Immunol Res 44 1-3 (2009) 112-126
80. Fischer A., Landais P., Friedrich W., et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency. Blood 83 4 (1994) 1149-1154
81. Antoine C., Muller S., Cant A., et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 361 9357 (2003) 553-560
82. Patel N.C., Chinen J., Rosenblatt H.M., et al. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. J Allergy Clin Immunol 122 6 (2008) 1185-1193
83. Haddad E., Landais P., Friedrich W., et al. Long-term immune reconstitution and outcome after HLA-nonidentical T-cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 91 10 (1998) 3646-3653
84. Roifman C.M., Grunebaum E., Dalal I., et al. Matched unrelated bone marrow transplant for severe combined immunodeficiency. Immunol Res 38 1-3 (2007) 191-200
85. Grunebaum E., Mazzolari E., Porta F., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 295 5 (2006) 508-518
86. Railey M.D., Lokhnygina Y., and Buckley R.H. Long-term clinical outcome of patients with severe combined immunodeficiency who received related donor bone marrow transplants without pretransplant chemotherapy or post-transplant GVHD prophylaxis. J Pediatr 155 6 (2009) 834-840 e1.
87. Mazzolari E., Forino C., Guerci S., et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 120 4 (2007) 892-899
88. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 105 2 (2005) 879-885
89. Filipovich A.H., Stone J.V., Tomany S.C., et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 97 6 (2001) 1598-1603
90. Ozsahin H., Cavazzana-Calvo M., Notarangelo L.D., et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 111 1 (2008) 439-445
91. The International Chronic Cooperative Study Group. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med 324 8 (1991) 509-516
92. Liese J., Kloos S., Jendrossek V., et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr 137 5 (2000) 687-693
93. Jones L.B., McGrogan P., Flood T.J., et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol 152 2 (2008) 211-218
94. Di Bartolomeo P., Di Girolamo G., Angrilli F., et al. Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant 4 6 (1989) 695-700
95. Schettini F., De Mattia D., Manzionna M.M., et al. Bone marrow transplantation for chronic granulomatous disease associated with cytochrome B deficiency. Pediatr Hematol Oncol 4 3 (1987) 277-279
96. Seger R.A., Gungor T., Belohradsky B.H., et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000. Blood 100 13 (2002) 4344-4350
97. Soncini E., Slatter M.A., Jones L.B., et al. Unrelated donor and HLA-identical sibling haematopoietic stem cell transplantation cure chronic granulomatous disease with good long-term outcome and growth. Br J Haematol 145 1 (2009) 73-83
98. Hoffmann T., Heilmann C., Madsen H.O., et al. Matched unrelated allogeneic bone marrow transplantation for recurrent malignant lymphoma in a patient with X-linked lymphoproliferative disease (XLP). Bone Marrow Transplant 22 6 (1998) 603-604
99. Jordan M.B., and Filipovich A.H. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant 42 7 (2008) 433-437
100. Qasim W., Cavazzana-Calvo M., Davies E.G., et al. Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. Pediatrics 123 3 (2009) 836-840
101. Isam H., and Al-Wahadneh A. Successful bone marrow transplantation in a child with X-linked hyper-IgM syndrome. Saudi J Kidney Dis Transpl 15 4 (2004) 489-493
102. Duplantier J.E., Seyama K., Day N.K., et al. Immunologic reconstitution following bone marrow transplantation for X-linked hyper IgM syndrome. Clin Immunol 98 3 (2001) 313-318
103. Rao A., Kamani N., Filipovich A., et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. Blood 109 1 (2007) 383-385
104. Tardieu M., Lacroix C., Neven B., et al. Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. Blood 106 1 (2005) 40-42